Armstrong Advisory Group’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.5K Hold
141
﹤0.01% 701
2026
Q1
$10K Hold
141
﹤0.01% 687
2025
Q4
$8.35K Hold
141
﹤0.01% 701
2025
Q3
$7.78K Hold
141
﹤0.01% 722
2025
Q2
$6.08K Hold
141
﹤0.01% 730
2025
Q1
$5.75K Hold
141
﹤0.01% 682
2024
Q4
$5.75K Hold
141
﹤0.01% 682
2024
Q3
$5.5K Hold
141
﹤0.01% 653
2024
Q2
$6.16K Hold
141
﹤0.01% 633
2024
Q1
$6.66K Hold
141
﹤0.01% 615
2023
Q4
$6.66K Hold
141
﹤0.01% 615
2023
Q3
$6.71K Hold
141
﹤0.01% 662
2023
Q2
$8.2K Hold
141
﹤0.01% 607
2023
Q1
$10.1K Hold
141
﹤0.01% 571
2022
Q4
$9.93K Buy
+141
New +$9.94K ﹤0.01% 584

Other funds holding NGVT

Armstrong Advisory Group's NGVT Position: Q2 2026 in Review

Armstrong Advisory Group held its Ingevity (NGVT) position steady in Q2 2026 at 141 shares worth $10.5K. The position accounts for ﹤0.01% of the portfolio, ranked #701.

Armstrong Advisory Group first reported a position in NGVT in Q4 2022 and has held it in 15 quarters since. 44 funds tracked by Wall St. Rank hold NGVT as of Q2 2026.

  • Armstrong Advisory Group held 141 shares of Ingevity worth $10.5K as of Q2 2026.
  • Armstrong Advisory Group left its Ingevity share count unchanged in Q2 2026.
  • Ingevity made up ﹤0.01% of Armstrong Advisory Group's portfolio in Q2 2026, its #701 holding.
  • Armstrong Advisory Group first reported a position in Ingevity in Q4 2022 and has held it in 15 quarters since.
  • 44 funds tracked by Wall St. Rank held Ingevity as of Q2 2026.

Based on Armstrong Advisory Group's 13F filing for Q2 2026, filed 13 Jul 2026.